ISRG on XNAS, Health Care, Intuitive Surgical Inc., job postings
Measures activity, not value. Not investment advice.
Quarterly revenue rose 22% to $3B but the stock fell 28% over 12 months.
GoodTwelve month revenue up 20% to $11.6B, with net profit up 7.7%
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.
expected around 13 Jan 2027 (an estimate: a year ago it reported on 14 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $3.3B, net income $522.8M.
31 Dec 2021RevenueNet incometallest bar $3.3B30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$3.3B
$522.8M
30 Jun 2026
$3.2B
$818.1M
31 Mar 2026
$3.0B
$821.5M
31 Dec 2025
$3.1B
$794.8M
30 Sep 2025
$2.7B
$704.4M
30 Jun 2025
$2.7B
$658.4M
31 Mar 2025
$2.4B
$698.4M
31 Dec 2024
$2.6B
$685.7M
30 Sep 2024
$2.2B
$565.1M
30 Jun 2024
$2.2B
$526.9M
31 Mar 2024
$2.0B
$544.9M
31 Dec 2023
$2.1B
$606.2M
30 Sep 2023
$1.9B
$415.7M
30 Jun 2023
$1.9B
$420.8M
31 Mar 2023
$1.8B
$355.3M
31 Dec 2022
$1.8B
$324.9M
30 Sep 2022
$1.7B
$324.0M
30 Jun 2022
$1.6B
$307.8M
31 Mar 2022
$1.6B
$365.6M
31 Dec 2021
$1.6B
$380.6M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$12.6B
$10.4B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+21%
+8.1%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$3.0B
$2.7B
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$8.26
$7.57
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
61.7%
61.2%
61.3%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
26.0%
27.0%
5.6%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
23.5%
26.3%
-2.7%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
18.0%
-20.0%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$3.6B
$2.3B
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$4.0B
$4.9B
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$0
$0
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$4.0B (net cash)
-$4.9B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.0
0.22
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$46.12
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
46.8
27.5
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
11.0
2.6
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
10.7
3.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
8.7
3.4
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$20.2M
bought $0, sold $20.2M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
0%
2,202 13F filers vs 2,203
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
84%
290.1M shares held by 13F filers (30 Sep 2026) of 346.6M outstanding (15 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
2.0%
7.1M shares sold short (30 Oct 2026) of 346.6M outstanding (15 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
2.5
7.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-3.6%
7.3M shares sold short in the report before, 7.1M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
41%
41% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 44%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
-16%
269 vs 322 applications
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+22%
$3.3B vs $2.7B (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+7.3%
$113.1M vs $105.4M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$180K
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
55
55 articles in the last 7 days; its usual week has 8.5 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
6.5×
55 articles in the last 7 days; its usual week has 8.5.
Unusual now sharp changes in the last 90 days, compared with its own past
Lobbying spend $180K, 2.4× its usual level
Price $399.05 on 20 Nov 2026, -28% over 12 months (12-month range $332.02 to $592.85)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders sold a net $65.3M in the last 12 months (the 12 months before: -$115.3M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 269 published in the last 12 months, -16% on the 12 months before.Revenue per quarter. Revenue $3.3B in the latest quarter, +22% on a year earlier.Capital spending per quarter. Capital spending $113.1M in the latest quarter, +7.3% on a year earlier.Institutional holders (13F filers). 2,202 13F filers reported holding it in the latest 13F quarter, +9.8% on a year earlier.Federal obligations. Federal obligations: -$123K published in the last 12 months, -100% on the 12 months before.Lobbying spend. Lobbying spend: $180K published in the last 12 months, -10% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.
Reported lobbying spend: $180K in Q3 2026, $80K in Q1 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
1 May 2019
New
FGS Global (US) LLC (Fka FGH Holdings LLC)for Intuitive Surgical, Inc.
Lobbying related to health care issues.Health issues, MED
Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). FDA regulation of medical devices.Health issues
Healthcare regulatory issues; comparative effectiveness research in healthcare; healthcare reimbursement issues; medical research issues; science, technology, and R&D policy issues Issues related to FDA medical device safetyHealth issues, MED
healthcare regulatory issues; comparative effectiveness research in healthcare; healthcare reimbursement issues; medical research issues; science, technology, and R&D policy issuesHealth issues, Medicare/Medicaid, Science/technology, MED
Two or more unrelated kinds of records unusual within 30 days
25 Oct 2022confirmed
Confirmed across sources Filings + Financials and Lobbying and Short interest and volume
Intuitive Surgical(ISRG): spent $169.1M on capital projects in the quarter ended 30 Sep 2022, 2.5× the same quarter last year; it also reported $290K of lobbying spend for the quarter ended 30 Sep 2022, 1.1× the same quarter last year; and it had 7.0M shares sold short in the 31 Oct 2022 report, 2.0× the same report last year. Three unrelated kinds of activity within 35 days.
Financials: Quarterly capital spending jump, became public on 25 Oct 2022
Lobbying: Lobbying spend jump, became public on 20 Oct 2022
Short interest and volume: Short interest spike, became public on 10 Nov 2022
Short interest and volume: Short interest spike, became public on 26 Nov 2022
The quarter ended 30 Sep 2022 against the 8 quarters before it.
this quarterearliernormal: $72.0MSee the evidence (4 changes)
Financials: Quarterly capital spending jump became public on 25 Oct 2022
Intuitive Surgical spent $169.1M on capital projects in the quarter ended 30 Sep 2022, 2.5× the same quarter last year.
This period
$169.1M (the quarter ended 30 Sep 2022)
Normal quarter (median of 8 earlier)
$72.0M
Typical spread (median absolute deviation)
$11.8M
How far from its usual level
+5.6
Same quarter last year
$68.3M
History used
5,113 days
the quarter ended 30 Sep 20228 earlier quartersnormal: $72.0M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
Lobbying: Lobbying spend jump became public on 20 Oct 2022
Intuitive Surgical reported $290K of lobbying spend for the quarter ended 30 Sep 2022, 1.1× the same quarter last year.
This period
$290K (the quarter ended 30 Sep 2022)
Normal quarter (median of 8 earlier)
$60K
Typical spread (median absolute deviation)
$0
How far from its usual level
+11.5
Same quarter last year
$270K
History used
4,656 days
the quarter ended 30 Sep 20228 earlier quartersnormal: $60K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Short interest and volume: Short interest spike became public on 10 Nov 2022
Intuitive Surgical had 7.0M shares sold short in the 31 Oct 2022 report, 2.0× the same report last year.
This period
7.0M (the 31 Oct 2022 report)
Normal report (median of 24 earlier)
3.4M
Typical spread (median absolute deviation)
358K
How far from its usual level
+6.8
Same report last year
3.6M
History used
1,767 days
the 31 Oct 2022 report24 earlier reportsnormal: 3.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Nov 2022
Intuitive Surgical had 6.3M shares sold short in the 15 Nov 2022 report, 2.3× the same report last year.
This period
6.3M (the 15 Nov 2022 report)
Normal report (median of 24 earlier)
3.5M
Typical spread (median absolute deviation)
430K
How far from its usual level
+4.4
Same report last year
2.8M
History used
1,782 days
the 15 Nov 2022 report24 earlier reportsnormal: 3.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
9 Aug 2022confirmed
Confirmed across sources Government contracts and Filings + Financials and Short interest and volume
Intuitive Surgical(ISRG): spent $130.5M on capital projects in the quarter ended 30 Jun 2022, 1.7× the same quarter last year; it also booked $32.8M in federal contract and grant obligations in July 2022, 7.3× the same month last year; and it had 6.2M shares sold short in the 31 Aug 2022 report, 5.1× the same report last year. Three unrelated kinds of activity within 49 days.
Financials: Quarterly capital spending jump, became public on 26 Jul 2022
Government contracts: Federal obligations jump, became public on 6 Aug 2022
Short interest and volume: Short interest spike, became public on 25 Aug 2022
Short interest and volume: Short interest spike, became public on 13 Sep 2022
The quarter ended 30 Jun 2022 against the 8 quarters before it.
this quarterearliernormal: $72.0MSee the evidence (4 changes)
Financials: Quarterly capital spending jump became public on 26 Jul 2022
Intuitive Surgical spent $130.5M on capital projects in the quarter ended 30 Jun 2022, 1.7× the same quarter last year.
This period
$130.5M (the quarter ended 30 Jun 2022)
Normal quarter (median of 8 earlier)
$72.0M
Typical spread (median absolute deviation)
$11.8M
How far from its usual level
+3.4
Same quarter last year
$75.7M
History used
5,021 days
the quarter ended 30 Jun 20228 earlier quartersnormal: $72.0M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
Government contracts: Federal obligations jump became public on 6 Aug 2022
Intuitive Surgical booked $32.8M in federal contract and grant obligations in July 2022, 7.3× the same month last year.
This period
$32.8M (July 2022)
Normal month (median of 5 earlier)
$4.2M
Typical spread (median absolute deviation)
$2.4M
How far from its usual level
+8.1
Same month last year
$4.5M
History used
5,417 days
July 20225 earlier monthsnormal: $4.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Short interest and volume: Short interest spike became public on 25 Aug 2022
Intuitive Surgical had 6.2M shares sold short in the 15 Aug 2022 report, 5.2× the same report last year.
This period
6.2M (the 15 Aug 2022 report)
Normal report (median of 24 earlier)
3.1M
Typical spread (median absolute deviation)
424K
How far from its usual level
+4.9
Same report last year
1.2M
History used
1,690 days
the 15 Aug 2022 report24 earlier reportsnormal: 3.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 13 Sep 2022
Intuitive Surgical had 6.2M shares sold short in the 31 Aug 2022 report, 5.1× the same report last year.
This period
6.2M (the 31 Aug 2022 report)
Normal report (median of 24 earlier)
3.2M
Typical spread (median absolute deviation)
374K
How far from its usual level
+5.3
Same report last year
1.2M
History used
1,706 days
the 31 Aug 2022 report24 earlier reportsnormal: 3.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
8 Feb 2022confirmed
Confirmed across sources Filings + Financials and Short interest and volume
Intuitive Surgical(ISRG): spent $150.9M on capital projects in the quarter ended 31 Dec 2021, 2.4× the same quarter last year, while it had 3.4M shares sold short in the 15 Mar 2022 report, 2.2× the same report last year. Two unrelated kinds of activity within 70 days.
Short interest and volume: Short interest spike, became public on 27 Jan 2022
Financials: Quarterly capital spending jump, became public on 8 Feb 2022
Short interest and volume: Short interest spike, became public on 10 Feb 2022
Short interest and volume: Short interest spike, became public on 26 Feb 2022
Short interest and volume: Short interest spike, became public on 10 Mar 2022
Short interest and volume: Short interest spike, became public on 25 Mar 2022
Short interest and volume: Short interest spike, became public on 12 Apr 2022
The quarter ended 31 Dec 2021 against the 8 quarters before it.
this quarterearliernormal: $72.0MSee the evidence (7 changes)
Short interest and volume: Short interest spike became public on 27 Jan 2022
Intuitive Surgical had 3.0M shares sold short in the 14 Jan 2022 report, 2.0× the same report last year.
This period
3.0M (the 14 Jan 2022 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
132K
How far from its usual level
+8.7
Same report last year
1.5M
History used
1,477 days
the 14 Jan 2022 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Financials: Quarterly capital spending jump became public on 8 Feb 2022
Intuitive Surgical spent $150.9M on capital projects in the quarter ended 31 Dec 2021, 2.4× the same quarter last year.
This period
$150.9M (the quarter ended 31 Dec 2021)
Normal quarter (median of 8 earlier)
$72.0M
Typical spread (median absolute deviation)
$11.8M
How far from its usual level
+4.5
Same quarter last year
$61.9M
History used
4,840 days
the quarter ended 31 Dec 20218 earlier quartersnormal: $72.0M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
Short interest and volume: Short interest spike became public on 10 Feb 2022
Intuitive Surgical had 3.6M shares sold short in the 31 Jan 2022 report, 2.8× the same report last year.
This period
3.6M (the 31 Jan 2022 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
133K
How far from its usual level
+11.3
Same report last year
1.3M
History used
1,494 days
the 31 Jan 2022 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Feb 2022
Intuitive Surgical had 4.3M shares sold short in the 15 Feb 2022 report, 3.5× the same report last year.
This period
4.3M (the 15 Feb 2022 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
133K
How far from its usual level
+15.1
Same report last year
1.2M
History used
1,509 days
the 15 Feb 2022 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 Mar 2022
Intuitive Surgical had 4.2M shares sold short in the 28 Feb 2022 report, 3.3× the same report last year.
This period
4.2M (the 28 Feb 2022 report)
Normal report (median of 24 earlier)
1.4M
Typical spread (median absolute deviation)
160K
How far from its usual level
+12.1
Same report last year
1.3M
History used
1,522 days
the 28 Feb 2022 report24 earlier reportsnormal: 1.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Mar 2022
Intuitive Surgical had 3.4M shares sold short in the 15 Mar 2022 report, 2.2× the same report last year.
This period
3.4M (the 15 Mar 2022 report)
Normal report (median of 24 earlier)
1.4M
Typical spread (median absolute deviation)
171K
How far from its usual level
+8.0
Same report last year
1.5M
History used
1,537 days
the 15 Mar 2022 report24 earlier reportsnormal: 1.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 Apr 2022
Intuitive Surgical had 3.1M shares sold short in the 31 Mar 2022 report, 2.3× the same report last year.
This period
3.1M (the 31 Mar 2022 report)
Normal report (median of 24 earlier)
1.4M
Typical spread (median absolute deviation)
261K
How far from its usual level
+4.2
Same report last year
1.4M
History used
1,553 days
the 31 Mar 2022 report24 earlier reportsnormal: 1.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
2 Nov 2026Filings change
filed a director or officer change (8-K item 5.02), its first in 90 days.
Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.
reported $180K of lobbying spend for the quarter ended 30 Sep 2026, 2.4× its normal quarter.
See the evidence
This period
$180K (the quarter ended 30 Sep 2026)
Normal quarter (median of 6 earlier)
$75K
Typical spread (median absolute deviation)
$5K
How far from its usual level
+5.2
History used
6,301 days
the quarter ended 30 Sep 20266 earlier quartersnormal: $75K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
had 7.2M shares sold short in the 28 Nov 2025 report, 2.1× the same report last year.
Same report last year: 3.5M; its normal report is 4.6M.
See the evidence
This period
7.2M (the 28 Nov 2025 report)
Normal report (median of 24 earlier)
4.6M
Typical spread (median absolute deviation)
456K
How far from its usual level
+3.9
Same report last year
3.5M
History used
2,891 days
the 28 Nov 2025 report24 earlier reportsnormal: 4.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 7.5M shares sold short in the 14 Nov 2025 report, 1.8× the same report last year.
Same report last year: 4.2M; its normal report is 4.5M.
See the evidence
This period
7.5M (the 14 Nov 2025 report)
Normal report (median of 24 earlier)
4.5M
Typical spread (median absolute deviation)
390K
How far from its usual level
+5.2
Same report last year
4.2M
History used
2,877 days
the 14 Nov 2025 report24 earlier reportsnormal: 4.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.9M shares sold short in the 31 Oct 2025 report, 1.8× the same report last year.
Same report last year: 3.9M; its normal report is 4.4M.
See the evidence
This period
6.9M (the 31 Oct 2025 report)
Normal report (median of 24 earlier)
4.4M
Typical spread (median absolute deviation)
433K
How far from its usual level
+3.8
Same report last year
3.9M
History used
2,863 days
the 31 Oct 2025 report24 earlier reportsnormal: 4.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 7.4M shares sold short in the 15 Oct 2025 report, 2.1× the same report last year.
Same report last year: 3.6M; its normal report is 4.3M.
See the evidence
This period
7.4M (the 15 Oct 2025 report)
Normal report (median of 24 earlier)
4.3M
Typical spread (median absolute deviation)
456K
How far from its usual level
+4.5
Same report last year
3.6M
History used
2,847 days
the 15 Oct 2025 report24 earlier reportsnormal: 4.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 8.2M shares sold short in the 30 Sep 2025 report, 2.2× the same report last year.
Same report last year: 3.7M; its normal report is 4.3M.
See the evidence
This period
8.2M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
4.3M
Typical spread (median absolute deviation)
394K
How far from its usual level
+6.7
Same report last year
3.7M
History used
2,832 days
the 30 Sep 2025 report24 earlier reportsnormal: 4.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
reported revenue of $2.4B for the quarter ended 31 Dec 2024, 1.3× the same quarter last year.
Same quarter last year: $1.9B; its normal quarter is $1.8B.
See the evidence
This period
$2.4B (the quarter ended 31 Dec 2024)
Normal quarter (median of 8 earlier)
$1.8B
Typical spread (median absolute deviation)
$116.0M
How far from its usual level
+3.2
Same quarter last year
$1.9B
History used
6,028 days
the quarter ended 31 Dec 20248 earlier quartersnormal: $1.8B
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
had 4.9M shares sold short in the 28 Jun 2024 report, 1.7× the same report last year.
Same report last year: 2.9M; its normal report is 3.1M.
See the evidence
This period
4.9M (the 28 Jun 2024 report)
Normal report (median of 24 earlier)
3.1M
Typical spread (median absolute deviation)
204K
How far from its usual level
+5.6
Same report last year
2.9M
History used
2,373 days
the 28 Jun 2024 report24 earlier reportsnormal: 3.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 155 13F filers open a new position in the quarter ended 31 Mar 2024, 1.8× the same quarter last year.
Same quarter last year: 86; its normal quarter is 92.5.
See the evidence
This period
155 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
92.5
Typical spread (median absolute deviation)
7.5
How far from its usual level
+5.6
Same quarter last year
86
History used
3,835 days
the quarter ended 31 Mar 20248 earlier quartersnormal: 92.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Showing the newest 40 of 174 entries; narrow the window or the kind of data to see older ones.
Not listed: 556 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001035267
Ticker
ISRG
Domain
intuitive.com
Employer name
Intuitive Surgical, Inc., Intuitive Surgical Operations, Inc. (2 unverified)
Hq location
CA|SUNNYVALE|94086 (1 unverified)
Lobbying client
intuitive surgical
Name
Guanxing Medical Device (Beijing) Co., Ltd, Intuitive Fluorescence Imaging LLC, Intuitive Rose, LLC, Intuitive Surgical ApS and 35 more
Uei
LLNKWMBRNH69
Wikidata
Q2743863
Wikipedia
Intuitive Surgical
DOL H-1B labor condition applications and PERM certifications1963 data points1 Oct 2019 to 28 Sep 2026
Federal lobbying disclosures (LDA)10 records, 197 data points1 Jul 1999 to 30 Sep 2026
SEC Form 13F institutional holdings12 records, 481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)135 records13 Jan 2016 to 2 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1473 data points31 Dec 2006 to 15 Oct 2026
SEC Form 4 insider transactions447 records, 1212 data points1 Feb 2016 to 20 Nov 2026
FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards181 records, 11232 data points1 Oct 2007 to 19 Oct 2026
Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026